Financials data is unavailable for this security.
View more
Year on year medmix AG 's net income fell -97.41% from 11.60m to 300.00k despite relatively flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 63.24% to 67.59%.
| Gross margin | 32.58% |
|---|---|
| Net profit margin | -0.21% |
| Operating margin | 3.00% |
| Return on assets | -0.10% |
|---|---|
| Return on equity | -0.38% |
| Return on investment | -0.12% |
More ▼
Cash flow in CHFView more
In 2023, cash reserves at medmix AG fell by 182.90m. However, the company earned 56.10m from its operations for a Cash Flow Margin of 11.53%. In addition the company used 80.60m on investing activities and also paid 153.80m in financing cash flows.
| Cash flow per share | 1.36 |
|---|---|
| Price/Cash flow per share | 6.19 |
| Book value per share | 11.30 |
|---|---|
| Tangible book value per share | 1.53 |
More ▼
Balance sheet in CHFView more
| Current ratio | 1.48 |
|---|---|
| Quick ratio | 1.06 |
| Total debt/total equity | 0.7895 |
|---|---|
| Total debt/total capital | 0.4361 |
More ▼
Growth rates in CHF
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -97.43%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
| EPS growth(5 years) | -65.66 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 57.80 |
